Advisornet Financial’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-200
Closed -$7.79K 2250
2025
Q3
$7.79K Hold
200
﹤0.01% 1595
2025
Q2
$7.31K Hold
200
﹤0.01% 1574
2025
Q1
$7.25K Hold
200
﹤0.01% 1507
2024
Q4
$7.81K Buy
200
+100
+100% +$3.9K ﹤0.01% 1379
2024
Q3
$3.66K Hold
100
﹤0.01% 1642
2024
Q2
$3.48K Hold
100
﹤0.01% 1530
2024
Q1
$3.63K Hold
100
﹤0.01% 1499
2023
Q4
$3.31K Hold
100
﹤0.01% 1586
2023
Q3
$3.04K Hold
100
﹤0.01% 1541
2023
Q2
$3.23K Sell
100
-120
-55% -$3.66K ﹤0.01% 1611
2023
Q1
$6.85K Hold
220
﹤0.01% 1402
2022
Q4
$6.51K Hold
220
﹤0.01% 1408
2022
Q3
$6K Hold
220
﹤0.01% 1460
2022
Q2
$7K Hold
220
﹤0.01% 1423
2022
Q1
$8K Buy
+220
New +$8.05K ﹤0.01% 1488

Other funds holding BOUT

Advisornet Financial's BOUT Position: Q4 2025 in Review

Advisornet Financial sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q4 2025, closing a stake of 200 shares — an estimated $7.79K sold.

Advisornet Financial first reported a position in BOUT in Q1 2022 and held it in 15 quarters. The position peaked at $8K in Q1 2022. 16 funds tracked by Wall St. Rank hold BOUT as of Q4 2025.

  • Advisornet Financial reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q4 2025 after selling out during the quarter.
  • Advisornet Financial sold 200 CapForce IBD Breakout Opportunities ETF shares in Q4 2025, an estimated $7.79K.
  • Advisornet Financial first reported a position in CapForce IBD Breakout Opportunities ETF in Q1 2022 and held it in 15 quarters.
  • Advisornet Financial's CapForce IBD Breakout Opportunities ETF position peaked at $8K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q4 2025.

Based on Advisornet Financial's 13F filing for Q4 2025, filed 20 Jan 2026.